Key points
- Psyence Group Inc. (CSE: PSYG) shareholders approved all matters at the company’s annual general and special meeting, including the proposed amalgamation with GoldCoast Resource Corp.
- The current board, Jody Aufrichtig, Alan Friedman and Warwick Corden-Lloyd, was re-elected to serve until the transaction closes or the next annual meeting.
- Conditional on completion of the transaction, shareholders also approved a new resulting-issuer board: Sir Sam Jonah, Tom Griffis, Michael Nikiforuk, Elia Crespo and Bobby Banson.
Toronto, Ontario – May 21, 2026 – Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company“) is pleased to announce the voting results from its annual general and special meeting of shareholders held today (the “Meeting“).
At the Meeting, shareholders approved all matters brought before the Meeting, including matters relating to the Company’s previously announced proposed amalgamation transaction involving Psyence Therapeutics Corp., a wholly owned subsidiary of the Company, and GoldCoast Resource Corp. (“GoldCoast“) (the “Transaction“).
The shareholders approved the election of the current board of directors of the Company, consisting of Jody Aufrichtig, Alan Friedman and Warwick Corden-Lloyd, to hold office until the next annual meeting of shareholders or until their successors are duly elected or appointed if the Transaction is not completed.
Shareholders also approved, conditional upon completion of the Transaction, the election of the proposed directors of the resulting issuer following completion of the Transaction, consisting of Sir Sam Jonah, Tom Griffis, Michael Nikiforuk, Elia Crespo and Bobby Banson.
